185 related articles for article (PubMed ID: 32987318)
1. Epigenetics modulates the complexity of the response to Immune Checkpoint Blockade.
Barragan I
EBioMedicine; 2020 Oct; 60():103005. PubMed ID: 32987318
[No Abstract] [Full Text] [Related]
2. Translational Control of Immune Evasion in Cancer.
Suresh S; O'Donnell KA
Trends Cancer; 2021 Jul; 7(7):580-582. PubMed ID: 33972197
[TBL] [Abstract][Full Text] [Related]
3. Epigenetics meets immune checkpoints.
Covre A; Coral S; Di Giacomo AM; Taverna P; Azab M; Maio M
Semin Oncol; 2015 Jun; 42(3):506-13. PubMed ID: 25965370
[TBL] [Abstract][Full Text] [Related]
4. The Role of m6A Epigenetic Modification in the Treatment of Colorectal Cancer Immune Checkpoint Inhibitors.
Tong H; Wei H; Smith AO; Huang J
Front Immunol; 2021; 12():802049. PubMed ID: 35069586
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and Treatment of Rheumatic Adverse Events Related to Immune Checkpoint Inhibitors.
Xiao Y; Zeng L; Shen Q; Zhou Z; Mao Z; Wang Q; Zhang X; Li Y; Yao W
J Immunol Res; 2020; 2020():2640273. PubMed ID: 32832568
[TBL] [Abstract][Full Text] [Related]
6. Thinking Small: Small Molecules as Potential Synergistic Adjuncts to Checkpoint Inhibition in Melanoma.
Chacon AC; Melucci AD; Qin SS; Prieto PA
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33810078
[TBL] [Abstract][Full Text] [Related]
7. Editorial: Dynamic Biomarkers of Response to Anti-Immune Checkpoint Inhibitors in Cancer.
Dermime S; Merhi M; Merghoub T
Front Immunol; 2021; 12():781872. PubMed ID: 34745152
[No Abstract] [Full Text] [Related]
8. Epigenetic Modifiers: Anti-Neoplastic Drugs With Immunomodulating Potential.
Maes K; Mondino A; Lasarte JJ; Agirre X; Vanderkerken K; Prosper F; Breckpot K
Front Immunol; 2021; 12():652160. PubMed ID: 33859645
[TBL] [Abstract][Full Text] [Related]
9. Immune checkpoint inhibitor associated neurotoxicity: Much more than meets the eye.
Raibagkar P
Immunol Lett; 2020 May; 221():72-74. PubMed ID: 32092358
[No Abstract] [Full Text] [Related]
10. Hiding in the dark: pan-cancer characterization of expression and clinical relevance of CD40 to immune checkpoint blockade therapy.
Yan C; Richmond A
Mol Cancer; 2021 Nov; 20(1):146. PubMed ID: 34758832
[TBL] [Abstract][Full Text] [Related]
11. Diversity of Dominant Peripheral T Cell Receptor Clone and Soluble Immune Checkpoint Proteins Associated With Clinical Outcomes Following Immune Checkpoint Inhibitor Treatment in Advanced Cancers.
Li Y; Wang J; Wu L; Li X; Zhang X; Zhang G; Xu S; Sun S; Jiao S
Front Immunol; 2021; 12():649343. PubMed ID: 34163469
[TBL] [Abstract][Full Text] [Related]
12. Age-Related Differences in Molecular Profiles for Immune Checkpoint Blockade Therapy.
Zhang QJ; Luan JC; Song LB; Cong R; Ji CJ; Zhou X; Xia JD; Song NH
Front Immunol; 2021; 12():657575. PubMed ID: 33936087
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic Mechanisms of Resistance to Immune Checkpoint Inhibitors.
Perrier A; Didelot A; Laurent-Puig P; Blons H; Garinet S
Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32708698
[TBL] [Abstract][Full Text] [Related]
14. Activating the Antitumor Immune Response in Non-Hodgkin Lymphoma Using Immune Checkpoint Inhibitors.
Joshi M; Ansell SM
J Immunol Res; 2020; 2020():8820377. PubMed ID: 33294467
[TBL] [Abstract][Full Text] [Related]
15.
Baniel CC; Heinze CM; Hoefges A; Sumiec EG; Hank JA; Carlson PM; Jin WJ; Patel RB; Sriramaneni RN; Gillies SD; Erbe AK; Schwarz CN; Pieper AA; Rakhmilevich AL; Sondel PM; Morris ZS
Front Immunol; 2020; 11():1610. PubMed ID: 32849544
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic and Genetic Regulation of PDCD1 Gene in Cancer Immunology.
Mishra A; Verma M
Methods Mol Biol; 2018; 1856():247-254. PubMed ID: 30178256
[TBL] [Abstract][Full Text] [Related]
17. Turning Cold into Hot: Firing up the Tumor Microenvironment.
Duan Q; Zhang H; Zheng J; Zhang L
Trends Cancer; 2020 Jul; 6(7):605-618. PubMed ID: 32610070
[TBL] [Abstract][Full Text] [Related]
18. Augmenting Anticancer Immunity Through Combined Targeting of Angiogenic and PD-1/PD-L1 Pathways: Challenges and Opportunities.
Hack SP; Zhu AX; Wang Y
Front Immunol; 2020; 11():598877. PubMed ID: 33250900
[TBL] [Abstract][Full Text] [Related]
19. Varied functions of immune checkpoints during cancer metastasis.
Safarzadeh A; Alizadeh M; Beyranvand F; Falavand Jozaaee R; Hajiasgharzadeh K; Baghbanzadeh A; Derakhshani A; Argentiero A; Baradaran B; Silvestris N
Cancer Immunol Immunother; 2021 Mar; 70(3):569-588. PubMed ID: 32902664
[TBL] [Abstract][Full Text] [Related]
20. Treatment Progress of Immune Checkpoint Blockade Therapy for Glioblastoma.
Zhang N; Wei L; Ye M; Kang C; You H
Front Immunol; 2020; 11():592612. PubMed ID: 33329578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
